Icon ICLR
NASDAQ ICLR
$169.68 -4.26 (-2.45%)
At close: Sep 17, 2026 · 4:00 PM EDT

Icon (ICLR) Capital Expenditures (2009 - 2026)

Icon's (ICLR) quarterly Capital Expenditures came in at -$42.4 million in Q2 2026, down 31.43% year-over-year from -$61.9 million in Q2 2025, and down 37.86% quarter-over-quarter from -$30.8 million in Q1 2026.

Analysis

Icon (ICLR) Capital Expenditures (2009 - 2026) Analysis & Trends

Icon (ICLR) has reported Capital Expenditures for 18 consecutive years, with -$42.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Capital Expenditures fell 31.43% year-over-year to -$42.4 million in Q2 2026; TTM through Jun 2026 was -$81.8 million, a 49.95% decrease from a year earlier, with the FY2025 full-year figure at -$69.8 million, down 22.86% from the prior year.
  • Capital Expenditures was -$42.4 million for Q2 2026 at Icon, down from -$30.8 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $50.0 million in Q4 2024 and troughed at -$57.0 million in Q4 2022.
  • A 5-year average of -$26.8 million and a median of -$31.5 million in 2023 frame the typical range for Capital Expenditures.
  • Across the five-year window, Capital Expenditures plunged 125.55% in 2022 and soared 194.79% in 2024, its largest moves.
  • Over 5 years, Capital Expenditures stood at -$57.0 million in 2022, then climbed by 7.55% to -$52.7 million in 2023, then surged by 194.79% to $50.0 million in 2024, then decreased by 9.75% to $45.1 million in 2025, then sank by 194.07% to -$42.4 million in 2026.
  • The last three Capital Expenditures figures came in at -$42.4 million (Q2 2026), -$30.8 million (Q1 2026), and $45.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 198.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 23.91 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -42.42 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 31.11 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 9.00 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 2.62 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 125,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -55,941.69
10 VivoSim Labs 1.37 Mn 1.37 Mn - 23,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -42.42 Mn
Mar 31, 2026 -30.77 Mn
Dec 31, 2025 45.10 Mn
Sep 30, 2025 -53.70 Mn
Jun 30, 2025 -32.28 Mn
Mar 31, 2025 -28.91 Mn
Dec 31, 2024 49.97 Mn
Sep 30, 2024 -43.33 Mn
Jun 30, 2024 -36.29 Mn
Mar 31, 2024 -27.15 Mn
Dec 31, 2023 -52.71 Mn
Sep 30, 2023 -29.10 Mn
Jun 30, 2023 -32.14 Mn
Mar 31, 2023 -26.74 Mn
Dec 31, 2022 -57.02 Mn
Sep 30, 2022 -37.31 Mn
Jun 30, 2022 -28.21 Mn
Mar 31, 2022 -19.63 Mn
Dec 31, 2021 -47.68 Mn
Sep 30, 2021 -24.41 Mn